Boiron SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Boiron SA with three other
companies in this sector in France:
sales of 861.88 million Euro [US$996.40 million]
of which 55%
was Companion Animals),
(807.12 million Euro [US$933.09 million]
of which 47%
was X-rays), and
(352.17 million Euro [US$407.14 million]
of which 56%
During the year ended December of 2017, sales at
Boiron SA were 617.54 million Euro (US$713.92 million).
a very small
increase of 0.5%
versus 2016, when the company's sales were 614.49 million Euro.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Boiron SA had sales
of 566.58 million Euro.
Sales of Otc Specialities and Other Products saw an increase
that was more than double the company's growth rate: sales were up
2.0% in 2017, from
299.67 million Euro to 305.55 million Euro.
Not all segments of Boiron SA experienced an increase in sales in 2017:
sales of Other fell 4.0% to 1.39 million Euro.
(However, this segment's sales were only a very small portion of the company's overall sales).
Boiron SA also experienced decreases in sales in
Non-Proprietary Homeopathic Medicines (down 0.9% to 310.59 million Euro)